Butarecbon
Brand names,
Butarecbon
Analogs
Butarecbon
Brand Names Mixture
- Alka Phenyl Tab (Aluminum Hydroxide + Magnesium Trisilicate + Phenylbutazone)
- Alka Phenylbutazone Tab (Aluminum Hydroxide + Magnesium Trisilicate + Phenylbutazone)
- Phenylone Plus Tab (Aluminum Hydroxide + Magnesium Trisilicate + Phenylbutazone)
Butarecbon
Chemical_Formula
C19H20N2O2
Butarecbon
RX_link
No information avaliable
Butarecbon
fda sheet
Butarecbon
msds (material safety sheet)
Butarecbon
Synthesis Reference
Ullmann's Encyklopaedie der Technischen Chemie 13, 298 (1962)
Butarecbon
Molecular Weight
308.374 g/mol
Butarecbon
Melting Point
105 oC
Butarecbon
H2O Solubility
47.5 mg/L
Butarecbon
State
Solid
Butarecbon
LogP
4.214
Butarecbon
Dosage Forms
Bolus; Liquid; Paste; Powder; Solution; Tablet
Butarecbon
Indication
For the treatment of backache and ankylosing spondylitis
Butarecbon
Pharmacology
Phenylbutazone is a synthetic, pyrazolone derivative. It is a nonhormonal anti-inflammatory, antipyretic compound useful in the management of inflammatory conditions. The apparent analgesic effect is probably related mainly to the compound's anti-inflammatory properties and arise from its ability to reduce production of prostaglandin H and prostacyclin. Prostaglandins act on a variety of cells such as vascular smooth muscle cells causing constriction or dilation, on platelets causing aggregation or disaggregation and on spinal neurons causing pain. Prostacylcin causes vascular constriction platelet disaggregation
Butarecbon
Absorption
No information avaliable
Butarecbon
side effects and Toxicity
Oral, LD50 = 238 mg/kg (mouse); Oral, LD50 = 781 mg/kg (rabbit); Oral, LD50 = 245 mg/kg (rat); Oral, LD50 = 375 mg/kg (rat)
Butarecbon
Patient Information
No information avaliable
Butarecbon
Organisms Affected
Humans and other mammals